ESC 365 - SGLT2 inhibitors should be given to all patients with heart failure - PRO.

ESC Premium Access

SGLT2 inhibitors should be given to all patients with heart failure - PRO.

Session: Controversies in Heart Failure: SGLT2 Inhibitors Should Be Given to All Patients

Topic: Chronic Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

138 presentations

34 followers

2 more presentations in this session

SGLT2 inhibitors should be given to all patients with heart failure - CON.

Speaker: Professor R. De Boer (Rotterdam, NL)

SGLT2 inhibitors should be given to all patients with heart failure - Discussion.

Access the full session

Controversies in Heart Failure: SGLT2 Inhibitors Should Be Given to All Patients

Speakers: Professor J. McMurray, Professor R. De Boer

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources